CISH (Chromogenic In-Situ Hybridization) is a new technique first published by Tanner and his collegues (Am J Pathol 2000, 157:1467-1472). It will likely prove to be much more economical than FISH (FISH can range up to ten times the cost of IHC), and can be conducted with an ordinary microscope. Because it is chromogenic, the […]
Read MorePartnership with PrognosDx offers tissue-based, global patterns of histone modification patient profiling for use in early stage drug discovery and various phases of clinical trials. Flagstaff, AZ – July 19, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced today an exclusive partnership with PrognosDx Health to provide pharmaceutical companies and cancer centers […]
Read MorePartnership with Vitro Molecular in histology and image analysis IHC biomarker development offers a complete companion diagnostics development service Flagstaff, AZ – July 5, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced it has expanded its partnership with Vitro Molecular in Miami Florida to provide validated IHC companion diagnostic development capabilities. […]
Read MoreImage analysis experts and board-certified pathologists team up to offer on-line digital pathology training in image analysis Flagstaff, AZ – June 5, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, launches on-line training program for image analysis in digital pathology. The first course is a once a week six-week series and is designed to […]
Read MoreBelow is an example of how histology pattern recognition can be used to determine thymic cortex to medulla ratios. The rat thymus was initially stained with classic H&E and then analyzed with image analysis tools. Below is the results with histology pattern recognition. By performing image analysis on a whole image slide of a rat […]
Read MoreIndustry veteran joins digital pathology services company Flagstaff Biosciences as CEO. Flagstaff, AZ – May 22, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced that Steven Potts has joined the company as Chief Executive Officer, with Dave Young continuing to serve as President of Flagship Biosciences. Steve has extensive experience in digital pathology, […]
Read MoreThe eye serves as an important organ for toxicology research. Below is a rodent H&E ocular cross-section, followed by pathologist-trained pattern recognition of each layer. This provides a larger and faster region of interest drawing than would be used with manual ROI drawing by a technician or pathologist. Depending on the performance, Flagship will use pattern […]
Read MoreFlagship Biosciences pathologists present two posters using quantitative pathology techniques in oncology research at the American Association for Cancer Research. Flagstaff, AZ – April 17, 2010 – Flagship Biosciences LLC,(Flagship) will present two posters at the Flagship Biosciences to present at the American Heart Association Boulder, CO – December 6, 2009 – Flagship Biosciences LLC,(Flagship) will […]
Read MoreAlliance offers a full pathology solution to pharmaceutical and biotechnology companies Flagstaff, AZ – April 2, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced today it has formed a strategic alliance with Experimental Pathology Laboratories, Inc. (EPL), a leading toxicologic pathology contract laboratory known worldwide for excellence in providing GLP preclinical […]
Read MoreBoulder, CO – March 8, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced it has selected Northern Arizona as its center for operations. “After a review of a number of locations, we selected Flagstaff as our histology image analysis and digital pathology center of excellence,” noted Dr. David Young, President of Flagship […]
Read More